ArticleJournal of gastrointestinal cancer2026

Pathological Complete Response in a Patient With HER2-Negative Esophagogastric Junction Cancer Undergoing Conversion-Intent Surgery After Ramucirumab Plus Paclitaxel Following Nivolumab-Based Chemotherapy: A Case Report.

Yuki Yamasaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.